Featured Research

from universities, journals, and other organizations

Scientists Use Bacterial Toxin To Kill Brain Tumors

Date:
July 1, 1999
Source:
The Hospital For Sick Children
Summary:
Researchers at The Hospital for Sick Children (HSC) and the University of Toronto (U of T) have used a toxin produced by the same bacteria that cause hamburger disease to completely eliminate malignant human brain tumors grown in mice. The research is published in the June issue of the scientific journal Oncology Research.

Toronto -- Researchers at The Hospital for Sick Children (HSC) and the University of Toronto (U of T) have used a toxin produced by the same bacteria that cause hamburger disease to completely eliminate malignant human brain tumors grown in mice. The research is published in the June issue of the scientific journal Oncology Research.

"E. coli is a common gastrointestinal bacterium," explains Dr. Cliff Lingwood, a senior scientist at HSC and a Professor of Laboratory Medicine and Pathobiology at the U of T. "Some E. coli strains produce a toxin known as verotoxin. Our earlier research has shown that, in the test tube, verotoxin kills certain brain tumor cells very efficiently. We wanted to determine if this was also the case in a living animal."

As part of her doctoral studies in Dr. Lingwood's laboratory, Dr. Sara Arab (now a clinical fellow in Medical Genetics at HSC) injected verotoxin directly into human astrocytoma brain tumors that had been grown in mice. After a single injection, the tumors had shrunk by half within 48 hours. Within seven to 15 days the tumors had completely disappeared and had not reappeared by the end of the experiment (60 days). Both the tumors and their blood vessels were killed by the toxin.

"We are very excited by this observation because astrocytoma is the most common type of malignant brain tumor and the prognosis is poor for patients with this diagnosis," explains HSC neurosurgeon James Rutka, a collaborator in the research and head of the Arthur and Sonia Labatt Brain tumor Research Centre. Approximately 20,000 people are diagnosed with brain tumors each year in Canada and the United States. "This discovery could be very promising because the verotoxin makes a two-pronged attack on the tumor: it destroys tumor cells and shuts down the tumor's blood supply."

While earlier HSC research has demonstrated that verotoxin-producing E. coli can cause kidney failure, primarily in very young children, the scientists suggest that a window of opportunity exists for verotoxin treatment in older patients.

###Plans are already underway for the next phase of the research: preliminary clinical trials in older children and adults. In that trial, verotoxin will be injected into residual glioblastoma cells following surgical removal of the majority of the tumor. Glioblastoma is the most malignant form of astrocytoma.

This research was supported by the Medical Research Council of Canada and The Hospital for Sick Children Foundation. Select Therapeutics Inc. holds an exclusive licensing agreement with The Hospital for Sick Children to bring the benefits of this research to market.


Story Source:

The above story is based on materials provided by The Hospital For Sick Children. Note: Materials may be edited for content and length.


Cite This Page:

The Hospital For Sick Children. "Scientists Use Bacterial Toxin To Kill Brain Tumors." ScienceDaily. ScienceDaily, 1 July 1999. <www.sciencedaily.com/releases/1999/07/990701070106.htm>.
The Hospital For Sick Children. (1999, July 1). Scientists Use Bacterial Toxin To Kill Brain Tumors. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1999/07/990701070106.htm
The Hospital For Sick Children. "Scientists Use Bacterial Toxin To Kill Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/1999/07/990701070106.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins